兴奋剂药物影响兴奋和奖励,而不是注意力
Benjamin P Kay1, Muriah D Wheelock2, Joshua S Siegel3
1Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
bioRxiv : the preprint server for biology
|June 6, 2025
概括
处方兴奋剂,如甲基胺,改变大脑运动和奖励区域的连接性,模仿足够睡眠的影响. 这些药物可以通过促进清醒来改善努力和坚持,而不是直接增强注意力网络.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 脑部成像 脑部成像
背景情况:
- 处方兴奋剂 (例如,甲基胺) 越来越多地被使用,特别是儿童,以获得所谓的注意力益处.
- 之前的功能磁共振成像 (fMRI) 研究显示,对刺激对大脑注意力,动作/运动和突出区域的影响有矛盾的结果.
- 调和这些相互矛盾的发现对于理解刺激机制至关重要.
研究的目的:
- 研究处方兴奋剂对儿童和成人大脑功能连接 (FC) 的影响.
- 为了确定刺激剂诱导的大脑变化是否与已知的神经化学途径 (上腺素,多巴胺) 保持一致.
- 探索刺激效应,兴奋,睡眠和认知表现之间的关系.
主要方法:
- 利用了来自青少年大脑认知发展 (ABCD) 研究的静止状态fMRI (rs-fMRI) 数据 (n=11,875;年龄为8-11岁).
- 雇佣了网络层面分析 (NLA) 和大脑范围的关联研究 (BWAS).
- 一个精确成像药物试验 (PIDT) 的验证结果,该试验对接受甲基胺 (40 mg) 的成年人进行了验证.
主要成果:
- 刺激剂在作用/运动区域改变了FC,与北上腺素载体分布一致.
- 连接性变化观察到突出 (SAL) 和顶层记忆网络 (PMN),与多巴胺和奖励激发的学习相关.
- 与兴奋剂相关的FC模式反映了充足的睡眠和唤醒,并减轻了睡眠剥夺对连接性和成绩的影响.
结论:
- 对大脑连接的刺激作用主要与促进清醒和奖励处理有关,而不是直接增强注意力网络.
- 结合的诺亚上腺和多巴胺作用可能会将大脑组织到一个更警觉和更有动力的状态.
- 结果解释了在刺激剂下改善的任务努力和持久性,独立于直接的注意力网络调制.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
1.5K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.5K
Stimulants
333
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
333
Adrenergic Agonists: Indirect-Acting Agents
1.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.9K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
343
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
343
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
421
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
421


